Company: HRTX
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0000950170-25-028374
Chunk: 190

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-02-27
Form: 10-K
Item: Item 8
Chunk 190
---
        $
        —

       We have not transferred any investment securities between the three levels of the fair value hierarchy. 

84

As of December 31, 2024, cash equivalents included $0.9 million of available-for-sale securities with contractual maturities of three months or less and short-term investments included $9.0 million of available-for-sale securities with contractual maturities of three months to one year. As of December 31, 2023, cash equivalents included $5.3 million of available-for-sale securities with contractual maturities of three months or less and short-term investments included $51.7 million of available-for-sale securities with contractual maturities of three months to one year. The money market funds as of December 31, 2024 and 2023 are included in cash and cash equivalents on the consolidated balance sheets.

4.Balance Sheet DetailsShort-Term InvestmentsThe following is a summary of our short-term investments (in thousands): 

        December 31, 2024

        Amortized Cost

        GrossUnrealizedGains

        GrossUnrealizedLosses

        EstimatedFair Value

        U.S. treasury bills and government agency obligations
         
        $
        14,860

        $
        8

        $
        —

        $
        14,868

        U.S. corporate debt securities

        11,699

        3

        —

        11,702

        Foreign corporate debt securities

        5,911

        2

        —

        5,913

        Foreign commercial paper

        998

        —

        —

        998

        Total
         
        $
        33,468

        $
        13

        $
        —

        $
        33,481

        December 31, 2023

        Amortized Cost

        GrossUnrealizedGains

        GrossUnrealizedLosses

        EstimatedFair Value

        U.S. treasury bills and government agency obligations
         
        $
        31,625

        $
        11

        $
        —

        $
        31,636

        U.S. corporate debt securities

        11,652

        1

        —

        11,653

        Foreign corporate debt securities

        5,459

        1

        —

        5,460

        U.S. commercial paper

        1,990